OTC: CLRPF - Clarity Pharmaceuticals Ltd

Altı ay boyunca karlılık: -20.21%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Clarity Pharmaceuticals Ltd

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2.

daha fazla ayrıntı
The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. The company has collaboration with GU Research Network for an investigator initiated Trial X-Calibur, using 64Cu-SAR-bisPSMA in known or suspected prostate cancer. Clarity Pharmaceuticals Ltd was incorporated in 2010 and is based in Sydney, Australia.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета aud
Сайт https://www.claritypharmaceuticals.com
Цена ао 5.55
Günlük fiyat değişimi: +16.59% (2.32)
Haftalık fiyat değişimi: -7.99% (2.94)
Aylık fiyat değişimi: -30.48% (3.891)
3 ayda fiyat değişimi: -54.35% (5.925)
Altı ayda fiyat değişimi: -20.21% (3.39)
Yıllık fiyat değişimi: +109.69% (1.29)
3 yılda fiyat değişimi: 0% (2.705)
5 yılda fiyat değişimi: 0% (2.705)
10 yılda fiyat değişimi: 0% (2.705)
Yılbaşından bu yana fiyat değişimi: -29.74% (3.85)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 10.16 1
P/E 0 0
EV/EBITDA 0 0
Toplam: 2.63

Yeterlik

İsim Anlam Seviye
ROA, % -31.35 0
ROE, % -33.85 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA 0 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 0 0
karlılık EPS, % 1.72 1
Toplam: 4.2
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
PFM Multi Manager Series-International Equity Fd 24827 0.01



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Alan John Taylor Ph.D. Executive Chairman 567.72k
Dr. Colin David Biggin Ph.D. MD, CEO & Executive Director 455.18k
Mr. David K. Green BEc., CA Chief Financial Officer 159.32k
Mr. Shaemus Gleason Executive Vice President of Operations N/A
Dr. Matthew Harris BSc., M.B.A., Ph.D. Chief Scientific Officer 130.94k
Michelle Parker Chief Clinical Officer N/A
Mr. Robert Vickery Company Secretary 109.28k
Ms. Lisa Sadetskaya Director of Corporate Communications.
Mary Bennett Head of Human Resource
Dr. Othon Gervasio Chief Medical Officer

Adres: Australia, Sydney, National Innovation Centre - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.claritypharmaceuticals.com